Bonnie Colville
Family Medicine · Houston, TXNPI 1477783744
Payments from drug & device makers
Across 2,119 payments — averaging $9261.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$16.9M
- Pfizer$1.3M
- GSK$620K
- Sanofi Pasteur Inc.$406K
- Astrazeneca UK Limited$344K
- AstraZeneca$27K
- plus $109 from 1 others
Across 18 payments — averaging $157.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi Pasteur Inc.$3K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 1,921 | $16,948,963 |
| Pfizer | 104 | $1,279,153 |
| GSK | 34 | $619,859 |
| Sanofi Pasteur Inc. | 55 | $406,202 |
| Astrazeneca UK Limited | 3 | $344,245 |
| AstraZeneca | 1 | $26,700 |
| Novo Nordisk | 1 | $109 |
How this compares
$19,625,230 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Houston
- Lisa HollowayHouston$30.1M
- Veronica FragosoHouston$24.5M
- Oscar de ValleHouston$12.8M
- van TranHouston$11M
- Joe PouzarHouston$10.7M
- Aalia Al-BarwaniHouston$6.8M
- Terence ChangHouston$3.3M
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.